LMAN2 Antikörper (C-Term)
Kurzübersicht für LMAN2 Antikörper (C-Term) (ABIN2302417)
Target
Alle LMAN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 284-314, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- LMAN2, CT (LMAN2, C5orf8, Vesicular integral-membrane protein VIP36, Glycoprotein GP36b, Lectin mannose-binding 2, Vesicular integral-membrane protein 36)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- LMAN2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 284-314 amino acids from the C-terminal region of human LMAN2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- LMAN2 (Lectin, Mannose-Binding 2 (LMAN2))
-
Andere Bezeichnung
- LMAN2
-
NCBI Accession
- NP_006807
-
UniProt
- Q12907
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-